Association Between DNA Methylation of MTHFR and Diabetic Kidney Disease
Journal of Diabetes Research · 2025
DOI: 10.1155/jdr/8096423 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes Research, 2025. Verfasst von Guoxiong Deng und 7 weiteren Autor:innen. Beteiligte Einrichtung: China-Japan Friendship Institute of Clinical Medicine Research, China-Japan Friendship Hospital, Beijing, China. Hauptthemen laut MEDLINE: Methylenetetrahydrofolate Reductase (NADPH2), DNA Methylation, Diabetic Nephropathies. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China-Japan Friendship Hospital, National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
The objective of this study is to explore the association between MTHFR DNA methylation and diabetic kidney disease (DKD).
Methods
This study involved 120 healthy people, 200 diabetes mellitus (DM) patients, and 200 DKD patients who visited China–Japan Friendship Hospital from 2022 to 2023. We selected four CpG islands for the detection of MTHFR DNA methylation: three located in the promoter region and one in Exon 2. The methylation rate of the MTHFR gene was measured using an enzyme digestion method combined with quantitative PCR. Clinical and biochemical characteristics between the two groups were also collected.
Results
The methylation rate of the three CpG islands in the promoter region showed no significant differences between the DM and DKD patients. However, a significant difference in the CpG island methylation rate of the MTHFR gene Exon 2 was observed (25.14% vs. 21.94%, p < 0.001). Logistic regression analysis indicated that the methylation rate of MTHFR Exon2 is negatively associated with the occurrence and progression of DKD (OR = 0.947, 95% CI [0.919, 0.977], p = 0.001), with adjustments for gender, age, BMI, smoking, drinking, CHO, and TG. Significant differences were observed in the methylation ratios in different HCY groups (24.51% vs. 21.99%, p = 0.031). Linear regression showed MTHFR Exon 2 methylation negatively correlated with homocysteine (HCY) levels ( p = 0.007).
Conclusion
Methylation of the MTHFR gene Exon 2 is a protective factor for DKD and may contribute to its onset and progression through its influence on HCY levels. These findings highlight the potential of MTHFR methylation as a biomarker for DKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- China-Japan Friendship Institute of Clinical Medicine Research, China-Japan Friendship Hospital, Beijing, China.
- Department of Clinical Laboratory, China-Japan Friendship Hospital, Beijing, China.
ORCID-Profile: Guoxiong Deng, Ziyi Feng, Xiaomu Kong, Peng Gao, Yongwei Jiang, Yi Liu, Meimei Zhao, Liang Ma
Förderung
- China-Japan Friendship Hospital
- National Natural Science Foundation of China
Zitieren
APA
Deng, G., Feng, Z., Kong, X., Gao, P., Jiang, Y., Liu, Y., Zhao, M., & Ma, L. (2025). Association Between DNA Methylation of MTHFR and Diabetic Kidney Disease. Journal of Diabetes Research. https://doi.org/10.1155/jdr/8096423
Vancouver
Deng G, Feng Z, Kong X, Gao P, Jiang Y, Liu Y, et al. Association Between DNA Methylation of MTHFR and Diabetic Kidney Disease. Journal of Diabetes Research. 2025. doi:10.1155/jdr/8096423
BibTeX
@article{Deng2025,
author = {Deng, Guoxiong and Feng, Ziyi and Kong, Xiaomu and Gao, Peng and Jiang, Yongwei and Liu, Yi and Zhao, Meimei and Ma, Liang},
title = {Association Between DNA Methylation of MTHFR and Diabetic Kidney Disease},
journal = {Journal of Diabetes Research},
year = {2025},
doi = {10.1155/jdr/8096423}
}
EUVIMED